I agree with your chart analysis. Fundamentals will come into play now to resolve the chart to the upside. Anticipation of uplisting, continuing rapid growth, 2 billionaire hedgefund investors with superlative track records, new products coming on stream.
IMO $1.50 is the next stop but it will be short lived. We will see $2.50 by the time the uplisting occurs. When it trades on NASDAQ a surge in demand for this new telemedicine future giant will propel price to $3.50 fairly quickly.
This, of course is speculation but speculation with strong factual support.